Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial.

Int J Mol Sci · 2023 · PMC10419295 · PMID 37569440

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

showed a trendp = 0.051so close (0.05 < p ≤ 0.1)

However, after 12 months, the active group showed a trend toward a reduction in TRACP-5b levels compared to the placebo group ( p = 0.051, Figure 2 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.